Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with nonmetastatic
|
|
- Jocelin McLaughlin
- 5 years ago
- Views:
Transcription
1 Crcinogenesis, 2015, Vol. 36, No. 2, doi: /crcin/bgu247 Advnce Access publiction December 18, 2014 Originl Mnuscript originl mnuscript Prognostic significnce of pretretment serum levels of lbumin, LDH nd totl bilirubin in ptients with nonmetsttic brest cncer Xion Liu 1,2, Qing H.Meng 3, Yunqing Ye 1, Michelle A.T. Hildebrndt 1, Jin Gu 1 nd Xifeng Wu 1, * 1 Deprtment of Epidemiology, The University of Texs MD Anderson Cncer Center, Houston, TX 77030, USA, 2 Deprtment of Brest Surgery, The First Affilited Hospitl with Nnjing Medicl University, Nnjing , Chin nd 3 Deprtment of Lbortory Medicine, The University of Texs MD Anderson Cncer Center, Houston, TX 77030, USA *To whom correspondence should be ddressed. Tel: ; Fx: ; Emil: xwu@mdnderson.org Abstrct Liver function tests (LFTs) hve been reported s independent predictors of non-liver disese-relted morbidity nd mortlity in generl popultion nd cncer ptients. In this study, we evluted the reltionship between pretretment serum LFTs nd overll survivl (OS) in non-metsttic Cucsin brest cncer ptients. Seven LFTs, including lbumin, lnine minotrnsferse, sprtte minotrnsferse, lkline phosphtse, lctte dehydrogense (LDH), totl bilirubin nd totl protein, were mesured in pretretment serum from 2425 femle Cucsin ptients with newly dignosed, histologiclly confirmed non-metsttic invsive brest cncer. Multivrite Cox model ws used to estimte hzrd rtio (HR) nd 95% confidence intervl (CI) for the ssocition of individul LFTs with 5-yer OS while djusting for ge, smoking sttus, pthologicl chrcteristics nd tretment regimen. We found tht serum lbumin, LDH nd totl bilirubin were significntly ssocited with 5-yer OS in multivrite Cox nlyses. Ptients with higher lbumin level exhibited 45% reduced risk of deth (HR = 0.55, 95% CI: ) compred with those with lower lbumin level. Ptients with higher totl bilirubin level hd nerly 40% reduction in the risk of deth (HR = 0.62, 95% CI: ) nd ptients with higher LDH levels hd 1.42-fold incresed risk of deth (HR = 1.42, 95% CI: ). Furthermore, cumultive nlysis showed significnt dose response trend of significntly incresing risk of deth with incresing number of unfvorble LFT levels. Our result highlighted the potentil of using pretretment serum levels of lbumin, LDH nd totl bilirubin s prognostic fctors for OS in ptients with non-metsttic brest cncer. Introduction Brest cncer is the most frequently occurring cncer in women worldwide. The 5-yer overll survivl (OS) for non-metsttic stge brest cncer ptients rnged from 72 to 100%; however, the 5-yer survivl for stge IV ptients ws disml 22%. Most ptients with non-metsttic brest cncer will receive locoregionl tretment, i.e. surgery with djuvnt rdiotherpy on indiction, nd djuvnt systemic therpy which my consist of chemotherpy, endocrine therpy, trget therpy or combintion of these tretments (1), wheres the primry tretment for metsttic brest cncer is systemic therpy. Modern brest cncer tretment cn be tilored to individul tumor chrcteristics, therefore, being ble to predict ptients prognosis will hve tremendous clinicl benefits by identifying most optionl therpeutic options for certin subgroups of ptients. Trditionl prognostic vribles, including tumor size, grde nd lymph node sttus, hve been integrted into the tumor, node nd metstsis stging system nd Nottinghm prognostic index (2,3). Recently, severl tumor-bsed moleculr mrkers, such s the expression of estrogen receptor lph, progesterone receptor nd humn epiderml growth fctor receptor-2, hve been strongly ssocited with OS (4). Furthermore, tumor-bsed gene expression profiling provided gret promise in predicting Received: September 19, 2014; Revised: November 26, 2014; Accepted: December 15, 2014 The Author Published by Oxford University Press. All rights reserved. For Permissions, plese emil: journls.permissions@oup.com. 243
2 244 Crcinogenesis, 2015, Vol. 36, No. 2 Abbrevitions CI HR LDH LFT OS confidence intervl hzrd rtio lctte dehydrogense liver function test overll survivl. brest cncer outcome (5,6). For exmple, the PAM50 gene signture ws pproved by the U.S. Food nd Drug Administrtion to ssess ptient s risk of distnt recurrence in postmenopusl women with node negtive (stge I or II) or node positive (stge II), hormone receptor-positive brest cncer. However, the discrimintory ccurcy with the ddition of PAM50 to the clinicl vribles ws still moderte with concordnce index of 0.78 (7). There is n urgent need to identify dditionl biomrkers which could improve the prediction of ptient s prognosis. Since blood re esily ccessible nd minimlly invsive, the identifiction of blood-bsed biomrkers re ppeling nd pose the gret potentil to enble ccurte prediction of individul s clinicl outcome nd clssify ptients into differentil prognostic subgroups. Liver function tests (LFTs), group of blood tests, usully consist of bilirubin, lbumin, totl protein, lnine minotrnsferse, sprtte minotrnsferse, gmm-glutmyltrnsferse, lkline phosphtse nd lctte dehydrogense (LDH). These tests re frequently included s bseline tests for mny different clinicl presenttions nd often obtined t initil consulttion since they re ssocited with mny spect of liver function including cellulr integrity, functionlity nd conditions relted to biliry trct. There is incresing interest for using LFT vribles s independent predictors of non-liver disese-relted morbidity nd mortlity in generl popultion nd cncer ptients (8,9). A few studies hve investigted the ssocitions of LFTs with mortlity in brest cncer (10 13). In this study, we collected dt from the lrge brest cncer ptient popultion t the University of Texs MD Anderson Cncer Center nd investigted the ssocition of selected pretretment LFTs with mortlity in non-metsttic brest cncer ptients. To our knowledge, this is the first study to ssess pnel of LFTs in lrge non-metsttic brest cncer ptient popultion. Mterils nd methods Ptient popultion nd dt collection This study included 2425 femle Cucsin ptients with newly dignosed, histologiclly confirmed, non-metsttic invsive brest cncer (stge I III). All ptients were recruited t the University of Texs MD Anderson Cncer Center. All ptients signed n informed consent before tking prt in the study. There were no other recruitment restrictions on ge, pthologicl fetures nd tretments. Informtion on ethnicity, smoking history nd fmily history of brest cncer ws ssessed by selfdministered questionnires. Clinicl nd pthologicl dt, tretment regimen nd follow-up informtion were bstrcted from medicl chrts. Albumin, lkline phosphtse, sprtte minotrnsferse, lnine minotrnsferse, totl bilirubin, LDH nd totl protein were mesured s prt of stndrd pnel of tests evluting ptients overll condition before tretment t the bseline visit. These tests were performed within 30 dys fter the dignosis nd before ny tretment by the Deprtment of Lbortory Medicine t MD Anderson Cncer Center. The study ws pproved by the MD Anderson Cncer Center Institutionl Review Bord. Sttisticl nlysis The endpoint of this study ws OS, which ws defined from the dte of dignosis to the dte of deth or the ltest follow-up. In this study, we presented the results for the 5-yer OS. STATA softwre, version 10 (SttCorp, College Sttion, TX) ws used for sttisticl nlyses. Chi-squre test or Fisher s exct test ws used to nlyze the differences in ptients host chrcteristics. Ptient ge ws ctegorized into <50 nd 50 yers of ge. Tumor size ws ctegorized into 1 cm, <1 cm to 2 cm, >2 cm to 3 cm, >3 cm to 4 cm, >4 cm to 5 cm nd >5 cm. Axillry lymph node positivity ws ctegorized into 0, 1 or 2, 3 or 4, 5 8, 9 19 nd 20. Nucler grde ws ctegorized into grde I, II nd III. Smoking sttus ws ctegorized into never, former nd current. Other strtified fctors, including first-degree reltive brest cncer history, lymph vessels invsion nd tretment regimens, were divided into two ctegories (yes versus no).the LFTs were dichotomized using cut-off points derived from spline modeling procedure which identified the optiml ctegoriztion through minimizing the distnce between estimted nd observed outcome vlues mong subjects in the sme ctegory s described in detil by O Brien (14), since over 90% of mrker levels were within norml rnge. The ssocition of the three significnt mrkers, lbumin, LDH nd totl bilirubin, were non-liner s illustrted by the spline curves shown in Supplementry Figure 1, vilble t Crcinogenesis Online. Multivrite Cox proportionl hzrds model ws used to ssess the effect of ech LFT vrible on 5-yer OS. Hzrd rtios (HRs) nd 95% confidence intervls (CIs) were estimted by fitting the multivrite Cox model while djusting for ge, smoking sttus, pthologicl fetures, first-degree reltive brest cncer history nd tretment regimens. Kpln Meier survivl nlysis nd log-rnk tests were used to ssess the differences in OS by individul LFTs. The cumultive effects of multiple unfvorble LFT levels were evluted for the three tests tht showed sttisticl significnce in the min nlysis. For ll nlyses, P vlue of <0.05 ws considered sttisticlly significnt. Results Ptient chrcteristics This study included 2425 femle Cucsin ptients with non-metsttic invsive brest cncer. The medin ge of ll ptients ws 54 yers (rnge: 22 98). There were 1030 ptients hving stge I tumor (42.47%), 1011 (41.69%) nd 384 ptients (15.84%) hving stge II nd III tumor, respectively. A totl of 1,281 ptients hd negtive xillry lymph nodes (52.82%), nd 644 hving lymph vessel invsion (26.56%). Estrogen receptor sttus included positivity (n = 1872, 77.20%), negtivity (n = 538, 22.19%) or unknown (n = 15, 0.62%). About 64.6% (n = 1566) of ll ptients were positive for progesterone receptor sttus, 34.64% (n = 840) negtive nd 0.78% (n = 19) unknown. As for Her2 sttus, 81.20% (n = 1969) ws negtive, 14.93% (n = 362) positive nd 3.88% (n = 94) unknown. The mjority of ptients hd djuvnt hormone therpy (n = 1709, 70.47%), nd 653 hd neodjuvnt chemotherpy (26.93%). Totlly, 1159 ptients (47.79%) received djuvnt chemotherpy (Tble 1). Assocition of pretretment LFT with OS We nlyzed the ssocition of the seven routine pretretment serum LFTs with 5-yer OS. Three LFTs including lbumin, LDH nd totl bilirubin were significntly ssocited with 5-yer OS in multivrite Cox nlyses, djusting for ge, smoking sttus, pthologicl chrcteristics, first-degree reltive brest cncer history nd tretment regimens (Tble 2, Figure 1). Ptient with higher lbumin level (>3.9 g/dl) were t 45% reduced risk of deth (HR = 0.55, 95% CI: , P = ) compred with those with lower lbumin level ( 3.9 g/dl). For bilirubin, ptients with totl bilirubin level >0.2 mg/dl hd better 5-yer OS nd their risks of deth reduced nerly 40% compred with tht of ptients with totl bilirubin level 0.2 mg/dl (HR = 0.62, 95% CI: , P = 0.003). The lbumin nd bilirubin remined significnt t P < (= 0.05/7) fter the Bonferroni correction for multiple comprisons. Ptients with higher LDH levels (>469 U/l) hd 1.42-fold incresed risk of deth compred with ptients with lower LDH levels ( 469 U/l) (HR = 1.42, 95% CI: ,
3 X.Liu et l. 245 Tble 1. Host chrcteristics of brest cncer ptients Vribles Clss Ded N (%) Alive N (%) P vlue Age, medin (rnge) 54 (22 98) Smoking sttus Never 124 (8.95%) 1262 (91.05%) Former 51 (6.68%) 712 (93.32%) Current 37 (13.41%) 239 (86.59%) First-degree reltive brest cncer history N 190 (9.55%) 1799 (90.45%) Y 22 (5.05%) 414 (94.95%) TNM stge I 37 (3.59%) 993 (96.41%) II 87 (8.61%) 924 (91.39%) III 88 (22.92%) 296 (77.08%) <0.001 Nucler grde I 6 (3.26%) 178 (96.74%) II 50 (4.58%) 1042 (95.42%) III 156 (13.58%) 993 (86.42%) <0.001 Tumor size 0 1 cm 41 (6.56%) 584 (93.44%) 1 2 cm 48 (5.13%) 888 (94.87%) 2 3 cm 39 (9.26%) 382 (90.74%) 3 4 cm 26 (14.69%) 151 (85.31%) 4 5 cm 16 (16.49%) 81 (83.51%) 5+ cm 42 (24.85%) 127 (75.15%) <0.001 Node positivity 0 64 (5.00%) 1217 (95.00%) 1 or 2 47 (7.83%) 553 (92.17%) 3 or 4 21 (9.59%) 198 (90.41%) (20.89%) 125 (79.11%) (23.02%) 97 (76.98%) (43.90%) 23 (56.10%) <0.001 Lymph vessels invsion N 109 (6.12%) 1672 (93.88%) Y 103 (15.99%) 541 (84.01%) <0.001 Neodjuvnt chemotherpy N 92 (5.19%) 1680 (94.81%) Y 120 (18.38%) 533 (81.62%) <0.001 Adjuvnt chemotherpy N 145 (11.45%) 1121 (88.55%) Y 67 (5.78%) 1092 (94.22%) <0.001 Adjuvnt hormone therpy N 111 (15.50%) 605 (84.50%) Y 101 (5.91%) 1608 (94.09%) <0.001 TNM, tumor, node nd metstsis. P vlue for the differences in ptients host chrcteristics between ded nd live. P = 0.01). In subgroup nlysis strtified by stge, we found tht lbumin levels were ssocited with OS regrdless of stges. LDH ppered to only influence OS in stge II nd III ptients. The ssocition of bilirubin with OS ppered to the strongest in stge I ptients (Tble 3). In subgroup nlysis strtified by moleculr subtypes, we observed similr estimted HRs for lbumin nd totl bilirubin while the estimtes for LDH were more evident in HR-positive nd humn epiderml growth fctor receptor-2-enriched subgroups. Cumultive effects of unfvorble LFT levels We then conducted joint nlysis to test whether ptients with more unfvorble pretretment LFT levels hd worse OS compred with those with fewer unfvorble LFT levels (Tble 4, Figure 2) Compred with ptient without ny unfvorble LFT level, ptients with 1, 2 nd 3 unfvorble LFT levels exhibited progressively incresed risks of deth with HRs of 1.39 (95% CI: ), 2.56 (95% CI: ), nd 3.34 (95% CI: ), respectively. The 5-yer OS rtes were 94.11, 91.30, nd 72.73% for ptients with 0, 1, 2 nd 3 unfvorble LFT levels, respectively (log-rnk P < ). Discussion In this study, we demonstrted tht pretretment serum lbumin, totl bilirubin nd LDH levels were ssocited with 5-yer OS in ptients with non-metsttic invsive brest cncer, nd the results remined significnt for lbumin, LDH nd bilirubin fter djusting for multiple comprisons using the stringent Bonferroni method, wheres lkline phosphtse, sprtte minotrnsferse, lnine minotrnsferse or totl protein levels were not ssocited with OS. Furthermore, there ws cumultive effect of those three unfvorble mrkers (lower lbumin level, higher LDH level nd lower totl bilirubin level) on ptients survivl. To illustrte the improvement of the three mrkers on the prediction of brest cncer survivl, we clculted re under the time-dependent receiver operting chrcteristic curves (AUC) for censored survivl dt using two models. The clinicl model included the trditionl prognostic fctors (ge, nucler grde, tumor size, number of positive lymph nodes, detection mode, lymphom or vsculr invsion), wheres the clinicl + mrker model included the three mrkers in ddition to the clinicl vribles described bove. The AUC incresed from for the clinicl model to for the clinicl + mrker model. Serum lbumin is one of the mostly commonly used mrkers for ssessing ptients nutritionl sttus. Albumin is produced by the liver nd is the mjor protein in blood, cting s key ntioxidnt, detoxifier nd trnsporter of importnt nutrients. In dvnced cncer ptients, the levels of serum lbumin fll shrply, becuse mlnutrition nd systemtic inflmmtory response to tumors both suppress lbumin synthesis (15). The prevlence of mlnutrition mong brest cncer ptients
4 246 Crcinogenesis, 2015, Vol. 36, No. 2 Tble 2. Assocition of biomrker levels with 5-yer OS Lb test Ded (N) Alive (N) Adjusted HR (95% CI) P vlue Albumin (g/dl) (reference) > ( ) ALP (IU/l) (reference) > ( ) 0.11 ALT (IU/l) (reference) > ( ) 0.09 AST (IU/l) (reference) > ( ) 0.12 LDH (IU/l) (reference) > ( ) 0.01 Totl bilirubin (mg/dl) (reference) > ( ) Totl protein (g/dl) (reference) > ( ) 0.96 ALP, lkline phosphtse; ALT, lnine minotrnsferse; AST, sprtte minotrnsferse. Adjusted for ge, smoking sttus, first-degree reltive brest cncer history, pthologicl chrcteristics nd tretment. reported by two French studies ws 20.5% (16) nd 18.3% (17), respectively. A Koren study lso showed over 51% of femle brest cncer ptients hd moderte to high risk of mlnutrition (18). Mlnutrition cn cuse mny clinicl consequences, including decresed life qulity, reduced tretment response nd incresed tretment-relted toxicity. Serum lbumin hs been used to ssess severity of disese, disese progression nd prognosis. Numerous studies hve evluted the ssocition of serum lbumin levels with the survivl of cncer ptients nd the results re firly consistent: lower serum lbumin levels re n independent indictor of worse survivl of vrious cncers (8). Severl studies with reltively smll smple sizes hve consistently reported the prognostic vlue of serum lbumin in brest cncer ptients. Heys et l. (12) reported tht pretretment serum lbumin, lymph node involvement nd dvnced stge were independent prognostic fctors of worse survivl using 77 lrge nd loclly dvnced brest cncer ptients treted with neodjuvnt chemotherpy. In nother study of 180 consecutively treted brest cncer ptients, Lis et l. (13) found tht norml levels of bseline serum lbumin levels reduced the risk of deth by 72% compred with low levels. Only tumor stge hd lrger impct on survivl thn serum lbumin levels. In the third study of 145 ptients with heptic metstses from brest cncer, Wyld et l. (11) identified low lbumin, dvnced ge nd estrogen receptor negtivity s independent predictors of poor survivl. To our knowledge, this current study is the lrgest study to evlute pretretment serum lbumin levels in brest cncer ptients nd is the only study tht hs sufficient smple size to exclusively focus on erly stge ptients. Our results re consistent with previous finding for other cncer sites (19 22) nd provide the strongest evidence tht lower serum lbumin level ws prognostic fctor for poor survivl in erly stge brest cncer ptients regrdless of stges. LDH is key enzyme in the conversion of pyruvte to lctte during nerobic conditions. LDH is ssocited with metbolic Figure 1. The Kpln Meier curves showing 5-yer OS mong brest cncer ptients ccording to pretretment lbumin levels (A), LDH levels (B) nd totl bilirubin levels (C). ctivities, inflmmtion, tissue injury nd neoplsms. Hypoxi in tumor microenvironment leds to high LDH levels. Mny studies hve shown tht LDH level could be used to estimte tumor bulk nd ctivity nd predict tretment response nd prognosis. High serum LDH levels hve been reported to be prognostic mrker for poor survivl in severl different cncer types (23 27). Few studies with reltively smll smple sizes nd focusing on metsttic brest cncer ptients hve ssessed the prognostic role of serum LDH level. Ymmoto et l. (28) found tht n elevtion of serum LDH significntly contributed to poorer survivl mong metsttic brest cncer ptients in Jpn. A recent study reported tht serum LDH level correlte strongly with survivl in ptients with bone metstsis from brest cncer (10). Our study showed tht higher levels of LDH predicted worse 5-yer OS in non-metsttic brest cncer ptients which ws consistent with previous reports. Furthermore, it ppered tht the prognostic effect of LDH ws only evident in stge II nd III ptients, but not in stge I ptients. It is likely tht higher LDH levels indicte high tumor ctivities nd occult metstsis, which my not be evident in stge I tumors. It is lso possible tht stge I brest cncer ptients hd excellent survivl, nd the 5-yer follow-up is not long enough to see the OS difference in stge I ptients.
5 X.Liu et l. 247 Tble 3. Assocition of biomrker levels with 5-yer OS strtified by stge nd moleculr subtypes Stge I Stge II Stge III Lb test Ded (N) Alive (N) HR (95% CI) Ded (N) Alive (N) HR (95% CI) Ded (N) Alive (N) HR (95% CI) Albumin (g/dl) > ( ) ( ) ( ) LDH (IU/l) > ( ) ( ) ( ) Totl bilirubin (mg/dl) > ( ) ( ) ( ) HR positive HER2 enriched Triple negtive Lb test Ded (N) Alive (N) HR (95% CI) Ded (N) Alive (N) HR (95% CI) Ded (N) Alive (N) HR (95% CI) Albumin (g/dl) > ( ) ( ) ( ) LDH (IU/l) > ( ) ( ) ( ) Totl bilirubin (mg/dl) > ( ) ( ) ( ) HR positive: ER+ or PR+, HER2 ; HER2 enriched: HER2+, regrdless of ER nd PR; Triple negtive: ER, PR, HER2. ER, estrogen receptor; HER2, humn epiderml growth fctor receptor-2; PR, progesterone receptor. Adjusted for ge, smoking sttus, first-degree reltive brest cncer history, pthologicl chrcteristics nd tretment. Tble 4. Cumultive effect of unfvorble LFT levels ssocited with 5-yer OS Number of dverse tests Ded (N) Alive (N) Adjusted HR (95% CI) P (reference) ( ) ( ) < ( ) Adjusted for ge, smoking sttus, first-degree reltive brest cncer history, pthologicl chrcteristics nd tretment. Oxidtive stress contributes to crcinogenesis. Bilirubin is potent ntioxidnt nd hs been shown to protect ginst cncer development. Lower serum bilirubin level hs been linked to incresed risk of crdiovsculr diseses nd cncer (29,30). The reltionship of serum bilirubin level with survivl hs been evluted in metsttic brest cncer ptients (11,31), nd the results showed tht hyperbilirubinemi ws ssocited with worse survivl. However, our study reveled tht non-metsttic brest cncer ptients with higher totl bilirubin levels hd better OS compred with those with lower bilirubin levels. This discrepncy my be due to the differences in ptient popultion. The bove two mentioned studies focused on hevily pretreted dvnced brest cncer ptients or brest cncer ptients with liver metstsis. Therefore, serum bilirubin level my hve different predictive effect in metsttic nd non-metsttic brest cncer ptients. Serum biomrkers re promising clinicl prognostic fctors in cncer ptients. However, single biomrker my not hve sufficient predictive power for clinicl ppliction. The combintion of Figure 2. Kpln Meier cumultive survivl plots for 5-yer OS ccording to unfvorble mrker score. multiple biomrkers through the cumultive nlysis cn improve the predictive power (19,32), s evidenced by previous ttempts of clculting prognostic scores (33). In our study, we found the ptients with the most unfvorble LFT levels hd worst 5-yer OS (5-yer OS rtes for ptients without unfvorble LFT versus ptients with three unfvorble LFTs: versus 72.73%), supporting the potentil of combining multiple prognostic fctors. The mjor strength of this study is the lrge smple size of non-metsttic brest cncer ptients who received tretment t single institution. The follow-up time ws reltively long. Our study provides strong evidence supporting tht pretretment serum levels of lbumin, LDH nd bilirubin re prognostic fctors for OS in non-metsttic brest cncer. These results
6 248 Crcinogenesis, 2015, Vol. 36, No. 2 suggest tht evlution of these three biomrkers my be useful for predicting prognosis in non-metsttic brest cncer. This study hs couple of limittions. Our study focused on Cucsin ptients; therefore, dditionl studies re needed before it cn be generlized to other ethnic groups. In ddition, vlidtion of our findings in n independent popultion is wrrnted. In conclusion, our study ws bsed on the lrge ptient cohort of 2425 non-metsttic brest cncer ptients. These results suggest tht evlution of serum lbumin, bilirubin nd LDH my be useful for predicting prognosis in non-metsttic brest cncer. Supplementry mteril Supplementry Figure 1 cn be found t Funding The University of Texs MD Anderson Cncer Center support for the Center for Trnsltionl nd Public Helth Genomics. Conflict of Interest Sttement: None declred. References 1. Erly Brest Cncer Trilists Collbortive Group. (1992) Systemic tretment of erly brest cncer by hormonl, cytotoxic, or immune therpy. 133 rndomised trils involving 31,000 recurrences nd 24,000 deths mong 75,000 women. Lncet, 339, D Eredit, G. et l. (2001) Prognostic fctors in brest cncer: the predictive vlue of the Nottinghm Prognostic Index in ptients with long-term follow-up tht were treted in single institution. Eur. J. Cncer, 37, Rvdin, P.M. et l. (2001) Computer progrm to ssist in mking decisions bout djuvnt therpy for women with erly brest cncer. J. Clin. Oncol., 19, Dwood, S. et l. (2010) Prognosis of women with metsttic brest cncer by HER2 sttus nd trstuzumb tretment: n institutionlbsed review. J. Clin. Oncol., 28, Pik, S. et l. (2004) A multigene ssy to predict recurrence of tmoxifen-treted, node-negtive brest cncer. N. Engl. J. Med., 351, Prker, J.S. et l. (2009) Supervised risk predictor of brest cncer bsed on intrinsic subtypes. J. Clin. Oncol., 27, Dowsett, M. et l. (2013) Comprison of PAM50 risk of recurrence score with oncotype DX nd IHC4 for predicting risk of distnt recurrence fter endocrine therpy. J. Clin. Oncol., 31, Gupt, D. et l. (2010) Pretretment serum lbumin s predictor of cncer survivl: systemtic review of the epidemiologicl literture. Nutr. J., 9, Liu, Z. et l. (2014) Complex ssocition between lnine minotrnsferse ctivity nd mortlity in generl popultion: systemtic review nd met-nlysis of prospective studies. PLoS One, 9, e Brown, J.E. et l. (2012) Serum lctte dehydrogense is prognostic for survivl in ptients with bone metstses from brest cncer: retrospective nlysis in bisphosphonte-treted ptients. Clin. Cncer Res., 18, Wyld, L. et l. (2003) Prognostic fctors for ptients with heptic metstses from brest cncer. Br. J. Cncer, 89, Heys, S.D. et l. (1998) Acute phse proteins in ptients with lrge nd loclly dvnced brest cncer treted with neo-djuvnt chemotherpy: response nd survivl. Int. J. Oncol., 13, Lis, C.G. et l. (2003) Is serum lbumin n independent predictor of survivl in ptients with brest cncer? JPEN. J. Prenter. Enterl Nutr., 27, O Brien, S.M. (2004) Cutpoint selection for ctegorizing continuous predictor. Biometrics, 60, Yeun, J.Y. et l. (1998) Fctors influencing serum lbumin in dilysis ptients. Am. J. Kidney Dis., 32 (6 suppl. 4), S118 S Hébuterne, X. et l. (2014) Prevlence of mlnutrition nd current use of nutrition support in ptients with cncer. JPEN. J. Prenter. Enterl Nutr., 38, Pressoir, M. et l. (2010) Prevlence, risk fctors nd clinicl implictions of mlnutrition in French Comprehensive Cncer Centres. Br. J. Cncer, 102, Wie, G.A. et l. (2010) Prevlence nd risk fctors of mlnutrition mong cncer ptients ccording to tumor loction nd stge in the Ntionl Cncer Center in Kore. Nutrition, 26, Boonpipttnpong, T. et l. (2006) Preopertive crcinoembryonic ntigen nd lbumin in predicting survivl in ptients with colon nd rectl crcinoms. J. Clin. Gstroenterol., 40, Nel, C.P. et l. (2009) Evlution of the prognostic vlue of systemic inflmmtion nd socioeconomic deprivtion in ptients with resectble colorectl liver metstses. Eur. J. Cncer, 45, Win, T. et l. (2008) Predicting survivl in potentilly curble lung cncer ptients. Lung, 186, Shrm, R. et l. (2008) Evlution of n inflmmtion-bsed prognostic score in ptients with dvnced ovrin cncer. Eur. J. Cncer, 44, Sgmn, U. et l. (1991) The prognostic significnce of pretretment serum lctte dehydrogense in ptients with smll-cell lung cncer. J. Clin. Oncol., 9, Floppi, L. et l. (2014) The role of LDH serum levels in predicting globl outcome in HCC ptients treted with sorfenib: implictions for clinicl mngement. BMC Cncer, 14, Kolev, Y. et l. (2008) Lctte dehydrogense-5 (LDH-5) expression in humn gstric cncer: ssocition with hypoxi-inducible fctor (HIF- 1lph) pthwy, ngiogenic fctors production nd poor prognosis. Ann. Surg. Oncol., 15, Koukourkis, M.I. et l. (2011) Prognostic nd predictive role of lctte dehydrogense 5 expression in colorectl cncer ptients treted with PTK787/ZK (vtlnib) ntingiogenic therpy. Clin. Cncer Res., 17, Scrtozzi, M. et l. (2012) Pre-tretment lctte dehydrogense levels s predictor of efficcy of first-line bevcizumb-bsed therpy in metsttic colorectl cncer ptients. Br. J. Cncer, 106, Ymmoto, N. et l. (1998) Construction nd vlidtion of prcticl prognostic index for ptients with metsttic brest cncer. J. Clin. Oncol., 16, Horsfll, L.J. et l. (2011) Serum bilirubin nd risk of respirtory disese nd deth. JAMA, 305, Novotný, L. et l. (2003) Inverse reltionship between serum bilirubin nd therosclerosis in men: met-nlysis of published studies. Exp. Biol. Med. (Mywood)., 228, Alexndre, J. et l. (2000) Fctors predicting for efficcy nd sfety of docetxel in compssionte-use cohort of 825 hevily pretreted dvnced brest cncer ptients. J. Clin. Oncol., 18, Rvishnkrn, P. et l. (2011) Clinicl significnce of preopertive serum interleukin-6 nd C-rective protein level in brest cncer ptients. World J. Surg. Oncol., 9, Tomit, M. et l. (2014) Prognostic significnce of pre- nd postopertive glsgow prognostic score for ptients with non-smll cell lung cncer. Anticncer Res., 34,
CheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationEfficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationImpact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors
Originl Article Impct of Positive Nodl Metstses in Ptients with Thymic Crcinom nd Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, nd Jennifer L. Sullivn, MD Introduction: Thymic crcinoms
More informationIntroduction. These patients benefit less from conventional chemotherapy than patients identified as MMR proficient or microsatellite stable 3-5
Nivolumb + Ipilimumb Combintion in Ptients With DNA Mismtch Repir-Deficient/Microstellite Instbility-High Metsttic Colorectl Cncer: First Report of the Full Cohort From CheckMte-142 Abstrct 553 André T,
More informationEsophageal carcinoma is the eighth most common cancer
ORIGINAL ARTICLE Tumor-Strom Rtio Is n Independent Predictor for Survivl in Esophgel Squmous Cell Crcinom Ki Wng, MD,* Wei M, MD,* Jinbo Wng, MD,* Ling Yu, MD, Xiomei Zhng, MD, Zhenbo Wng, MD, Bingxu Tn,
More informationUsing proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experience
ORIGINAL ARTICLE Using prolifertive mrkers nd Oncotype DX in therpeutic decision-mking for brest cncer: the B.C. experience E. Bxter bsc,* L. Gondr btech pdc, C. Lohrisch md, S. Chi md, K. Gelmon md, M.
More informationLung cancer is the leading cause of cancer death worldwide, EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
Originl Article EGFR Muttion nd Brin Metstsis in Pulmonry Adenocrcinoms Dong-Yeop Shin, MD,* Im Il N, MD,* Cheol Hyeon Kim, MD, PhD, Sunhoo Prk, MD, PhD, HeeJong Bek, MD, PhD, nd Sung Hyun Yng, MD, PhD*
More informationSupplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationOriginal Article. Breast Care 2016;11: DOI: /
Originl Article Brest Cre 2016;11:323 327 DOI: 10.1159/000452079 Published online: October 24, 2016 Neodjuvnt Chemotherpy with Docetxel, Crbopltin nd Weekly Trstuzumb Is Active in HER2-Positive Erly Brest
More informationMOLECULAR AND CLINICAL ONCOLOGY 7: , 2017
MOLECULAR AND CLINICAL ONCOLOGY 7: 787-797, 2017 Evlution of epiderml growth fctor receptor serum levels nd their ssocition with clinicopthologicl chrcteristics in ptients with colorectl cncer MEHMET KARABULUT
More informationPatient Survival After Surgical Treatment of Rectal Cancer
Originl Article Ptient Survivl After Surgicl Tretment of Rectl Cncer Impct of Surgeon nd Hospitl Chrcteristics Dvid A. Etzioni, MD, MSHS 1,2 ; Toni M. Young-Fdok, MD, MS 1 ; Robert R. Cim, MD, MA 2,3 ;
More informationSupplementary Online Content
Supplementry Online Content Rieckmnn N, Kronish IM, Shpiro PA, Whng W, Dvidson KW. Serotonin reuptke inhibitor use, depression, nd long-term outcomes fter n cute coronry : prospective cohort study. JAMA
More informationThe RUTHERFORD-2 trial in heterozygous FH: Results and implications
The RUTHERFORD-2 tril in heterozygous FH: Results nd implictions Slide deck kindly supplied s n eductionl resource by Professor Derick Rl MD PhD Crbohydrte & Lipid Metbolism Reserch Unit University of
More informationOne of the most important biological mechanisms of
Brief Report Serum Thymidine Kinse 1 Activity in the Prognosis nd Monitoring of Chemotherpy in Lung Cncer Ptients: A Brief Report Benjmin Nismn, PhD,* Hovv Nechushtn, MD, PhD,* Him Birn, MD, Hds Gntz-Sorotsky,
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationAge related differences in prognosis and prognostic factors among patients with epithelial ovarian cancer
MOLECULAR AND CLINICAL ONCOLOGY 9: 329-334, 2018 Age relted differences in prognosis nd prognostic fctors mong ptients with epithelil ovrin cncer KENJI YOSHIKAWA, TAKESHI FUKUDA, RYO UEMURA, HIROAKI MATSUBARA,
More informationORIGINAL ARTICLE ABSTRACT INTRODUCTION
ORIGINAL ARTICLE LOSS OF EPCAM STAINING CORRELATES WITH POOR OUTCOME IN CRC, Wng et l. Reduction in membrnous immunohistochemicl stining for the intrcellulr domin of epithelil cell dhesion molecule correltes
More informationClinical manifestations in patients with alpha-fetoprotein producing gastric cancer
Curr Oncol, Vol. 21, pp. e394-399; doi: http://dx.doi.org/10.3747/co.21.1768 CLINICAL MANIFESTATIONS IN AFP PRODUCING GASTRIC CANCER ORIGINAL ARTICLE Clinicl mnifesttions in ptients with lph-fetoprotein
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationEfficacy of Sonidegib in Patients With Metastatic BCC (mbcc)
AAD 216 eposter 3368 Efficcy of Sonidegib in Ptients With Metsttic BCC (mbcc) Colin Morton, 1 Michel Migden, 2 Tingting Yi, 3 Mnish Mone, 3 Dlil Sellmi, 3 Reinhrd Dummer 4 1 Stirling Community Hospitl,
More informationBody mass index, waist-to-hip ratio, and metabolic syndrome as predictors of middle-aged men's health
Originl Article - Sexul Dysfunction/Infertility pissn 2005-6737 eissn 2005-6745 Body mss index, wist-to-hip rtio, nd metbolic syndrome s predictors of middle-ged men's helth Jung Hyun Prk *, In-Chng Cho
More informationAsian Journal of Andrology (2017) 19,
(2017) 19, 20 25 2017 AJA, SIMM & SJTU. All rights reserved 1008-682X www.sindro.com; www.jndrology.com Prostte Cncer Open Access ORIGINAL ARTICLE Refining the Americn Urologicl Assocition nd Americn Society
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationMOLECULAR AND CLINICAL ONCOLOGY 5: , 2016
MOLECULAR AND CLINICAL ONCOLOGY 5: 429-436, 2016 Improvement of survivl with postmstectomy rdiotherpy in ptients with 1-3 positive xillry lymph nodes: A systemtic review nd met-nlysis of the current literture
More informationCommunity. Profile Powell County. Public Health and Safety Division
Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationRelation of Tumor Size, Lymph Node Status, and Survival in
Reltion of Tumor Size, Lymph Node Sttus, nd Survivl in 24,74 Brest Cncer Cses CHRISTINE L. CARTER, PHD, MPH,* CAROL ALLEN, PHD,t AND DONALD E. HENSON, MD* Two of the most importnt prognostic indictors
More informationA review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
MEDICAL ONCOLOGY A review of the ptterns of docetxel use for hormone-resistnt prostte cncer t the Princess Mrgret Hospitl S.N. Chin MD,* L. Wng MSc, M. Moore MD,* nd S.S. Sridhr MD MSc* ABSTRACT Bckground
More informationMetformin and breast cancer stage at diagnosis: a population-based study
ORIGINAL ARTICLE METFORMIN AND BREAST CANCER STAGE AT DIAGNOSIS, Leg et l. Metformin nd brest cncer stge t dignosis: popultion-bsed study I.C. Leg md msc,* K. Fung msc,* P.C. Austin phd, nd L.L. Lipscombe
More informationClinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationAdjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice
doi: 10.1054/ bjoc.2001.2035, vilble online t http://www.idelibrry.com on http://www.bjcncer.com Adjuvnt chemotherpy for colon crcinom with positive lymph nodes: use nd benefit in routine helth cre prctice
More informationCase Report INTRODUCTION CASE REPORT. pissn eissn X
pissn 2287-2728 eissn 2287-285X Cse Report Clinicl nd Moleculr Heptology 2018;24:424-429 Complete cure of dvnced heptocellulr crcinom with right drenl glnd metstsis nd portl vein thrombosis by multiple
More informationCommunity. Profile Anaconda- Deer Lodge County. Public Health and Safety Division
Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12
More informationNeutrophil lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors
2454 Neutrophil lymphocyte rtio predicts survivl in pncretic neuroendocrine tumors GUOPEI LUO 1 3*, CHEN LIU 1 3*, HE CHENG 1 3*, KAIZHOU JIN 1 3, MENG GUO 1 3, YU LU 1 3, JIANG LONG 1 3, JIN XU 1 3, QUANXING
More informationUniversity of Texas Health Science Center, San Antonio, San Antonio, Texas, USA
Lung Cncer Chemotherpy Given Ner the End of Life by Community Oncologists for Advnced Non-Smll Cell Lung Cncer Jose R. Murillo, Jr., Jim Koeller b,c Methodist Hospitl, Houston, Texs, USA; b University
More informationProphylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications
Gstric Cncer (2018) 21:703 709 https://doi.org/10.1007/s10120-017-0781-y ORIGINAL ARTICLE Prophylctic effect of neodjuvnt chemotherpy in gstric cncer ptients with postopertive complictions Kojiro Eto 1
More informationAmerican Joint Committee on Cancer Staging and Clinicopathological High-Risk Predictors of Ocular Surface Squamous Neoplasia
Americn Joint Committee on Cncer Stging nd Clinicopthologicl High-Risk Predictors of Oculr Surfce Squmous Neoplsi A Study From Tertiry Eye Center in Indi Sheetl Chuhn, MSc; Seem Sen, MD; Anjn Shrm, PhD;
More informationThe potential future of targeted radionuclide therapy: implications for occupational exposure? P. Covens
The potentil future of trgeted rdionuclide therpy: implictions for occuptionl exposure? Introduction: Trgeted Rdionuclide Therpy (TRT) Systemic tretment Molecule lbelled with rdionuclide delivers toxic
More informationAbstract. Background. Aim. Patients and Methods. Patients. Study Design
Impct of the Use of Drugs nd Substitution Tretments on the Antivirl Tretment of Chronic Heptitis C: Anlysis of Complince, Virologicl Response nd Qulity of Life (CHEOBS). Melin, 1 J.-. Lng, D. Ouzn, 3 M.
More informationSignificance of Expression of TGF- in Pulmonary Metastasis in Non-small Cell Lung Cancer Tissues
Originl Article Significnce of Expression of in Pulmonry Metstsis in Non-smll Cell Lung Cncer Tissues Hisshi Sji, Hruhiko Nkmur, Idiris Awut, Norihito Kwski, Msru Hgiwr, Akihiko Ogt, Mkoto Hosk, Tkmoto
More informationBreast-Conserving Surgery Under Local Anesthesia in Elderly Patients with Severe Cardiorespiratory Comorbidities: A Hospital-Based Case-Control Study
Originl Article Brest Cre 2017;12:29 33 DOI: 10.1159/000455003 Published online: Februry 8, 2017 Brest-Conserving Surgery Under Locl in Elderly Ptients with Severe Crdiorespirtory Comorbidities: A Hospitl-Bsed
More informationDA XU *, XIAOFENG LIU *, LIJUN WANG and BAOCAI XING
ONCOLOGY LETTERS Heptectomy plus djuvnt trnsctheter rteril chemoemboliztion improves the survivl rte of ptients with multicentric occurrence of heptocellulr crcinom DA XU *, XIAOFENG LIU *, LIJUN WANG
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationA cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis
Originl Article A cross-sectionl nd follow-up study of leukopeni in tuberculosis ptients: prevlence, risk fctors nd impct of nti-tuberculosis tretment Fei-Shen Lin 1 *, Mei-Ying Wu 2 *, Wen-Jun Tu 3, Hong-Qiu
More informationCHEST. Thyroid transcription factor 1 (TTF-1) is an important. Original Research
CHEST Originl Reserch Clinicl Significnce of Thyroid Trnscription Fctor-1 in Advnced Lung Adenocrcinom Under Epiderml Growth Fctor Receptor Tyrosine Kinse Inhibitor Tretment Kuei-Pin Chung, MD; Yen-Tsung
More informationAnalysis of Risk Factors for the Development of Incisional and Parastomal Hernias in Patients after Colorectal Surgery
Originl Article Journl of the Koren Society of J Koren Soc Coloproctol 2012;28(6):299-303 http://dx.doi.org/10.3393/jksc.2012.28.6.299 pissn 2093-7822 eissn 2093-7830 Anlysis of Risk Fctors for the Development
More informationRelationship Between Hospital Performance on a Patient Satisfaction Survey and Surgical Quality
Reserch Originl Investigtion Reltionship Between Hospitl Performnce on Ptient Stisfction Survey nd Surgicl Qulity Greg D. Scks, MD, MPH; Elise H. Lwson, MD, MSHS; Aron J. Dwes, MD; Mrci M. Russell, MD;
More informationRisks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria
Clinicl Prctice: Mini-Review Received: My 20, 2016 Accepted fter revision: December 14, 2016 Published online: Jnury 27, 2017 Risks for All-Cuse Mortlity: Strtified by Age, Estimted Glomerulr Filtrtion
More informationENERGY CONTENT OF BARLEY
ENERGY CONTENT OF BARLEY VARIATION IN THE DIETARY ENERGY CONTENT OF BARLEY Shwn Firbirn, John Ptience, Hnk Clssen nd Ruurd Zijlstr SUMMARY Formultion of commercil pig diets requires n incresing degree
More informationComparison of three simple methods for the
J. clin. Pth. (1967), 2, 5 Comprison of three simple methods for the ssessment of 'free' thyroid hormone T. M. D. GIMLETTE1 From the Rdio-Isotope Lbortory, St. Thoms's Hospitl, London SYNOPSIS A dilysis
More informationCommunity. Profile Carter County. Public Health and Safety Division
Community Helth Profile 2015 Crter County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationImpact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting
Impct of Phrmcist Intervention on Dibetes Ptients in n Ambultory Setting Julie Stding, PhrmD, CDE, Jmie Herrmnn, PhrmD, Ryn Wlters, MS, Chris Destche, PhrmD, nd Aln Chock, PhrmD Dibetes is the seventh-leding
More informationCharacteristics of hip involvement in patients with ankylosing spondylitis in Korea
ORIGINAL ARTICLE Koren J Intern Med 2017;32:158-164 Chrcteristics of hip involvement in ptients with nkylosing spondylitis in Kore Hyemin Jeong, Yeong Hee Eun, In Young Kim, Hyungjin Kim, Jejoon Lee, Eun-Mi
More informationStudy on the association between PI3K/AKT/mTOR signaling pathway gene polymorphism and susceptibility to gastric
JBUON 2017; 22(6): 1488-1493 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mil: editoril_office@jbuon.com ORIGINAL ARTICLE Study on the ssocition between PI3K/AKT/mTOR signling pthwy gene polymorphism
More informationOpioid Use and Survival at the End of Life: A Survey of a Hospice Population
532 Journl of Pin nd Symptom Mngement Vol. 32 No. 6 December 2006 NHPCO Originl Article Opioid Use nd Survivl t the End of Life: A Survey of Hospice Popultion Russell K. Portenoy, MD, Un Sibircev, BA,
More informationInhaled Corticosteroid Is Associated With an Increased Risk of TB in Patients With COPD
CHEST Originl Reserch Inhled Corticosteroid Is Associted With n Incresed Risk of TB in Ptients With COPD Jung-Hyun Kim, MD ; Ji-Soo Prk, MD ; Kyung-Ho Kim, MD ; Hye-Cheol Jeong, MD ; Eun-Kyung Kim, MD
More informationOriginal Article Prognostic and clinicopathologic significance of AEG-1/MTDH and E-cadherin expression in human gallbladder carcinoma
Int J Clin Exp Pthol 2018;11(12):6025-6031 www.ijcep.com /ISSN:1936-2625/IJCEP0086349 Originl Article Prognostic nd clinicopthologic significnce of AEG-1/MTDH nd E-cdherin expression in humn gllbldder
More informationCorrelation between CT features and liver function and p53 expression in hepatitis, cirrhosis and hepatocellular carcinoma
ONCOLOGY LETTERS Correltion between CT fetures nd liver function nd p53 expression in heptitis, cirrhosis nd heptocellulr crcinom YAHUI HU, JING WU, SHA LI nd XIAOXIAO ZHAO Deprtment of Nucler Medicine,
More informationOriginal Article Serum tumor markers used for predicting esophagogastric junction adenocarcinoma in esophageal malignancy
Int J Clin Exp Med 2016;9(6):11859-11864 www.ijcem.com /ISSN:1940-5901/IJCEM0025330 Originl Article Serum tumor mrkers used for predicting esophgogstric junction denocrcinom in esophgel mlignncy Yongkng
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationMetabolic Syndrome and Health-related Quality of Life in Obese Individuals Seeking Weight Reduction
Metbolic Syndrome nd Helth-relted Qulity of Life in Obese Individuls Seeking Weight Reduction Adm Gilden Tsi 1, Thoms A. Wdden 1, Dvid B. Srwer 1, Robert I. Berkowitz 1, Leslie G. Womble 1, Louise A. Hesson
More informationRisk of Colorectal Cancer by Subsite in a Swedish Prostate Cancer Cohort
Specil Report Risk of Colorectl Cncer by Subsite in Swedish Prostte Cncer Cohort Yunxi Lu, MD, PhD, Rickrd Ljung, MD, PhD, Ann Mrtling, MD, PhD, nd Mts Lindbld, MD, PhD Bckground: The reltionship between
More informationImproved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study
Journl of Heptology 37 (2002) 78 86 www.elsevier.com/locte/jhep Improved prognosis of postopertive heptocellulr crcinom ptients when treted with functionl foods: prospective cohort study Yoichi Mtsui*,
More informationComparative effectiveness of the tumour diagnostics,
Gut, 1987, 28, 323-329 Comprtive effectiveness of the tumour dignostics, C 19-9, C 125 nd crcinoembryonic ntigen in ptients with diseses of the digestive system K SKMOTO, Y HG, R YOSHIMR, H GMI, Y YOKOYM,
More informationClassic Papillary Thyroid Carcinoma with Tall Cell Features and Tall Cell Variant Have Similar Clinicopathologic Features
The Koren Journl of Pthology 2014; 48: 201-208 ORIGINAL ARTICLE Clssic Ppillry Thyroid Crcinom with Tll Cell Fetures nd Tll Cell Vrint Hve Similr Clinicopthologic Fetures Woo Jin Oh 1 Young Sub Lee 1 Uiju
More informationFertility in Norwegian testicular cancer patients
DOI: 0.054/ bjoc.999.0989, vilble online t http://www.idelibrry.com on Fertility in Norwegin testiculr cncer ptients SD Fosså nd Ø Krvdl 2 The Norwegin Rdium Hospitl, Montebello, N-030 Oslo, Norwy; 2 The
More informationphosphatase isoenzyme activity: estimation of
J Clin Pthol 1988;41:202-206 Quntittive method for determining serum lkline phosphtse isoenzyme ctivity: estimtion of intestinl component M J PEAKE, M PEJAKOVIC, G H WHITE From the Deprtment ofbiochemistry
More informationHealth-Related Quality of Life and Symptoms of Depression in Extremely Obese Persons Seeking Bariatric Surgery
Oesity Surgery, 15, 3-39 Helth-Relted Qulity of Life nd Symptoms of Depression in Extremely Oese Persons Seeking Britric Surgery Anthony N. Frictore, PhD; Thoms A. Wdden, PhD; Dvid B. Srwer, PhD; Myles
More informationMethylation of a Panel of MicroRNA Genes Is a Novel Biomarker for Detection of Bladder Cancer
EUROPEAN UROLOGY 6 (1) 191 11 vilble t www.sciencedirect.com journl homepge: www.europenurology.com Urothelil Cncer Methyltion of Pnel of MicroRNA Genes Is Novel Biomrker for Detection of Bldder Cncer
More informationReport of the Conference on Low Blood
1046 Report of the Conference on Low Blood Cholesterol: Mortlity Associtions Dvid Jcobs, PhD; Henry Blckburn, MD; Millicent Higgins, MD; Dwyne Reed, MD, PhD; Hiroysu Iso, MD; Grdner McMilln, MD, PhD; Jmes
More informationRegistre des Tumeurs Digestives du Calvados, CJF INSERM 96-03, Faculté de Médecine, Avenue de Côte de nacre, Caen cedex, France;
British Journl of Cncer (1999) 81(2), 5 9 Article no. bjoc.1999.0692 Colorectl cncer fter negtive Hemoccult II test nd progrmme sensitivity fter first round of screening: the experience of the Deprtment
More informationInput from external experts and manufacturer on the 2 nd draft project plan Stool DNA testing for early detection of colorectal cancer
Input externl experts nd mnufcturer on the 2 nd drft project pln Stool DNA testing for erly detection of colorectl cncer (Project ID:OTJA10) All s nd uthor s replies on the 2nd drft project pln Stool DNA
More informationMortality of patients with multiple sclerosis: a cohort study in UK primary care
Mortlity of ptients with multiple sclerosis: cohort study in UK primry cre The Hrvrd community hs mde this rticle openly vilble. Plese shre how this ccess benefits you. Your story mtters Cittion Jick,
More informationBreast carcinoma grading by histologic features has
Originl Articles Mitotic Index of Invsive Brest Crcinom Achieving Cliniclly Meningful Precision nd Evluting Tertil Cutoffs John S. Meyer, MD; Eric Costto, PhD; Hns Peter Grf, PhD Context. Mitotic figure
More informationIMpower133: Primary PFS, OS, and safety in a Ph1/3 study of 1L atezolizumab + carboplatin + etoposide in extensive-stage SCLC
IMpower133: Primry PFS, OS, nd sfety in Ph1/3 study of 1L tezolizumb + crbopltin + etoposide in extensive-stge SCLC S. V. Liu, 1 A. S. Mnsfield, 2 A. Szczesn, 3 L. Hvel, 4 M. Krzkowski, 5 M. J. Hochmir,
More informationBMI and Mortality: Results From a National Longitudinal Study of Canadian Adults
nture publishing group BMI nd Mortlity: Results From Ntionl Longitudinl Study of Cndin Adults Hether M. Orpn 1, Jen-Mrie Berthelot 2,3, Mrk S. Kpln 4, Dvid H. Feeny 5,6, Bentson McFrlnd 7 nd Nncy A. Ross
More informationTumor Vascularity Does Not Predict Response to Yttrium-90 Radioembolization for Hepatic Metastases from Colorectal Cancer
Originl Article 3 Tumor Vsculrity Does Not Predict Response to Yttrium-90 Rdioemboliztion for Heptic Metstses from Colorectl Cncer Alipi V. Nydenov Willim P. Hrris 2 Guy E. Johnson 3 Dniel S. Hippe 4 Siddhrth
More informationClinical Pattern of Recurrent Disease during the Follow-Up of Rectal Carcinoma
Originl Pper Received: December 20, 2016 Accepted: Februry 13, 2017 Published online: Mrch 14, 2017 Clinicl Pttern of Recurrent Disese during the Follow-Up of Rectl Crcinom Thijs Wieldrijer Pscl Bruin
More informationMulticenter Randomized Phase 2 Clinical Trial of a Recombinant Human Endostatin Adenovirus in Patients with Advanced Head and Neck Carcinoma
The Americn Society of Gene & Cell Therpy originl rticle Multicenter Rndomized Phse Clinicl Tril of Recombinnt Humn Endosttin Adenovirus in Ptients with Advnced Hed nd Neck Crcinom Wen Ye, Rnyi Liu, Chngchun
More informationStart ORKAMBI today. INDICATIONS AND USAGE IMPORTANT SAFETY INFORMATION. Sydney Age 4
F O R H E A L T H C A R E P R O F E S S I O N A L S For ptients ge 2 yers nd older who re homozygous for the F508del muttion 1,2 Modify the course. Strt tody. Sydney Age 4 F508del/F508del INDICATIONS AND
More informationFeeding state and age dependent changes in melaninconcentrating hormone expression in the hypothalamus of broiler chickens
Supplementry Mterils Epub: No 2017_23 Vol. 65, 2018 https://doi.org/10.183/bp.2017_23 Regulr pper Feeding stte nd ge dependent chnges in melninconcentrting hormone expression in the hypothlmus of broiler
More informationSystematic review of actual 10-year survival following resection for hepatocellular carcinoma
DOI:10.1111/j.1477-2574.2012.00446.x HPB SYSTEMATIC REVIEW Systemtic review of ctul 10-yer survivl following resection for heptocellulr crcinom Annelise M. Gluer 1, Nichols Cocco 1, Jerome M. Lurence 1,2,
More informationClinical statistics analysis on the characteristics of pneumoconiosis of Chinese miner population
Originl Article Clinicl sttistics nlysis on the chrcteristics of pneumoconiosis of Chinese miner popultion Mei-Fng Wng 1 *, Run-Ze Li 2 *, Ying Li 2, Xue-Qin Cheng 1, Jun Yng 1, Wen Chen 3, Xing-Xing Fn
More informationONCOLOGY LETTERS 14: , China Medical University, Shenyang, Liaoning , P.R. China
4890 Expression of vsculr endothelil growth fctor nd cspse 3 in mucinous brest crcinom nd infiltrting ductl crcinom not otherwise specified, nd the correltion with disese free survivl QIULI WANG 1, LISHA
More informationColon Cancer Treatment: Are There Racial Disparities in an Equal-Access Healthcare System?
ORIGINAL CONTRIBUTION Colon Cncer Tretment: Are There Rcil Disprities in n Equl-Access Helthcre System? Abegil A. Gill, M.P.H 1 Lindsey Enewold, Ph.D. 1 Sheli H. Zhm, Sc.D. 2 Crig D. Shriver, M.D. 3,4,5
More informationSymptoms of Sleep Disordered Breathing and Risk of Cancer: A Prospective Cohort Study
SYMPTOMS OF SDB AND RISK OF CANCER: A PROSPECTIVE COHORT STUDY http://dx.doi.org/10.5665/sleep.3030 Symptoms of Sleep Disordered Brething nd Risk of Cncer: A Prospective Cohort Study Anne Sofie Christensen,
More informationSafety and Tolerability of Subcutaneous Sarilumab and Intravenous Tocilizumab in Patients With RA
Sfety nd Tolerbility of Subcutneous Srilumb nd Intrvenous Tocilizumb in Ptients With RA Pul Emery, 1 Jun Rondon, 2 Anju Grg, 3 Hubert vn Hoogstrten, 3 Neil M.H. Grhm, 4 Ming Liu, 4 Nncy Liu, 3 Jnie Prrino,
More informationY. Yazici 1, D. Moniz Reed 2, C. Klem 2, L. Rosenblatt 2, G. Wu 2, J.M. Kremer 3
Greter remission rtes in ptients with erly versus long-stnding disese in biologic-nive rheumtoid rthritis ptients treted with btcept: post hoc nlysis of rndomised clinicl tril dt Y. Yzici 1, D. Moniz Reed
More informationP (RCC) was first done in the late 1930s and reported in
Pulmonry Resection of Metsttic Renl Cell Crcinom Robert J. Cerfolio, MD, Mrk S. Allen, MD, Clude Deschmps, MD, Richrd C. Dly, MD, Steven L. Wllrichs, BS, Victor F. Trstek, MD, nd Peter C. Pirolero, MD
More informationEuropean Journal of Internal Medicine
Europen Journl of Internl Medicine 22 (2011) 399 406 Contents lists vilble t ScienceDirect Europen Journl of Internl Medicine journl homepge: www.elsevier.com/locte/ejim Originl rticle Incidence of cute
More informationSingle-Molecule Studies of Unlabelled Full-Length p53 Protein Binding to DNA
Single-Molecule Studies of Unlbelled Full-Length p53 Protein Binding to DNA Philipp Nuttll, 1 Kidn Lee, 2 Pietro Ciccrell, 3 Mrco Crminti, 3 Giorgio Ferrri, 3 Ki- Bum Kim, 2 Tim Albrecht 1* 1 Imperil College
More informationThe Effects of Small Sized Rice Bowl on Carbohydrate Intake and Dietary Patterns in Women with Type 2 Diabetes
Originl Article doi: 10.4093/kdj.2010.34.3.166 pissn 1976-9180 eissn 2093-2650 The Effects of Smll Sized Rice Bowl on Crbohydrte Intke nd Dietry Ptterns in Women with Type 2 Dibetes Hee-Jung Ahn 1, *,
More informationHigh EGFR mrna expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy
INTERNATIONAL JOURNAL OF ONCOLOGY 38: 629-641, 2011 High EGFR mrna expression is prognostic fctor for reduced survivl in pncretic cncer fter gemcitbine-bsed djuvnt chemotherpy Hyto Fujit 1, Kenoki Ohuchid
More informationHuman Immunodeficiency Virus / Acquired Immunodeficiency Syndrome Knowledge and Risk Factors in Ethiopian Military Personnel
MILITARY MEDICINE, 169, 3:221, 2004 Humn Immunodeficiency Virus / Acquired Immunodeficiency Syndrome Knowledge nd Risk Fctors in Ethiopin Militry Personnel Gurntor: Ludmil N. Bkhirev, MD MPH Contributors:
More informationXII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV
XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies
More informationFat intake in patients newly diagnosed with type 2 diabetes: a 4-year follow-up study in general practice
Originl ppers Ft intke in ptients newly dignosed with type 2 dibetes: 4-yer follow-up study in generl prctice Floris A vn de Lr, Eloy H vn de Lisdonk, Peter L B J Lucssen, J M H Tigchelr, Sski Meyboom,
More information